{
  "cik": 1830214,
  "cik_padded": "0001830214",
  "entityName": "Ginkgo Bioworks Holdings, Inc.",
  "fiscal_years": [
    {
      "accn": "0001628280-26-012346",
      "filed": "2026-02-26",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 7665000.0,
        "cash": 167202000.0,
        "eps_diluted": -5.64,
        "free_cash_flow": -178724000.0,
        "net_income": -312763000.0,
        "operating_cash_flow": -171059000.0,
        "operating_income": -315278000.0,
        "revenue": 170155000.0,
        "stockholders_equity": 508590000.0,
        "total_assets": 1119696000.0,
        "total_liabilities": 611106000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 1.2015690438270512,
        "revenue_growth_yoy": -0.250560466519558,
        "roa_avg2y": -0.25049646696527433,
        "roa_period_end": -0.27932849630614026,
        "roe_avg2y": -0.5107802405262574,
        "roe_period_end": -0.6149609705263572
      }
    },
    {
      "accn": "0001628280-26-012346",
      "filed": "2026-02-26",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 62541000.0,
        "cash": 561572000.0,
        "eps_diluted": -10.54,
        "free_cash_flow": -382126000.0,
        "net_income": -547029000.0,
        "operating_cash_flow": -319585000.0,
        "operating_income": -559757000.0,
        "revenue": 227043000.0,
        "stockholders_equity": 716058000.0,
        "total_assets": 1377449000.0,
        "total_liabilities": 661391000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.9236556256616084,
        "revenue_growth_yoy": -0.09708297707343262,
        "roa_avg2y": -0.35955739319591784,
        "roa_period_end": -0.3971319446309809,
        "roe_avg2y": -0.603381847662433,
        "roe_period_end": -0.7639450994193208
      }
    },
    {
      "accn": "0001628280-26-012346",
      "filed": "2026-02-26",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 40801000.0,
        "cash": 944073000.0,
        "eps_diluted": -18.37,
        "free_cash_flow": -336301000.0,
        "net_income": -892869000.0,
        "operating_cash_flow": -295500000.0,
        "operating_income": -864406000.0,
        "revenue": 251455000.0,
        "stockholders_equity": 1097152000.0,
        "total_assets": 1665342000.0,
        "total_liabilities": 568190000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.5178771947733769,
        "revenue_growth_yoy": -0.4736197577589564,
        "roa_avg2y": -0.42470419151308914,
        "roa_period_end": -0.5361475300568892,
        "roe_avg2y": -0.6302391907473242,
        "roe_period_end": -0.8138061089074258
      }
    },
    {
      "accn": "0001628280-26-012346",
      "filed": "2026-02-26",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 52271000.0,
        "cash": 1315792000.0,
        "eps_diluted": -50.2,
        "free_cash_flow": -304469000.0,
        "net_income": -2104929000.0,
        "operating_cash_flow": -252198000.0,
        "operating_income": -2208952000.0,
        "revenue": 477706000.0,
        "stockholders_equity": 1736277000.0,
        "total_assets": 2539321000.0,
        "total_liabilities": 803044000.0
      },
      "period_end": "2022-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.4625091503256681,
        "revenue_growth_yoy": 0.5221468469300943,
        "roa_avg2y": -0.9131396992523931,
        "roa_period_end": -0.8289337976569326,
        "roe_avg2y": -1.2986807303212384,
        "roe_period_end": -1.21232326408747
      }
    },
    {
      "accn": "0001628280-25-007819",
      "filed": "2025-02-25",
      "fiscal_year": 2021,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 56521000.0,
        "cash": 1550004000.0,
        "eps_diluted": -1.39,
        "free_cash_flow": -310339000.0,
        "net_income": -1830047000.0,
        "operating_cash_flow": -253818000.0,
        "operating_income": -1828467000.0,
        "revenue": 313837000.0,
        "stockholders_equity": 1505365000.0,
        "total_assets": 2070990000.0,
        "total_liabilities": 503611000.0
      },
      "period_end": "2021-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.3345441138860011,
        "revenue_growth_yoy": 3.0940422922890276,
        "roa_avg2y": -1.3328126029853506,
        "roa_period_end": -0.88365805725764,
        "roe_avg2y": -1.8609944064826025,
        "roe_period_end": -1.2156832396129842
      }
    },
    {
      "accn": "0001628280-24-008052",
      "filed": "2024-02-29",
      "fiscal_year": 2020,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 57821000.0,
        "cash": 380801000.0,
        "eps_diluted": -0.1,
        "free_cash_flow": -193651000.0,
        "net_income": -126609000.0,
        "operating_cash_flow": -135830000.0,
        "operating_income": -137027000.0,
        "revenue": 76657000.0,
        "stockholders_equity": 461376000.0,
        "total_assets": 675153000.0,
        "total_liabilities": 205101000.0
      },
      "period_end": "2020-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_period_end": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.44454197877652935,
        "revenue_growth_yoy": 0.41475343274767457,
        "roa_period_end": -0.1875263829087629,
        "roe_period_end": -0.2744160944652518
      }
    },
    {
      "accn": "0000950170-23-007461",
      "filed": "2023-03-13",
      "fiscal_year": 2019,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD"
      },
      "fundamentals": {
        "capex": 22219000.0,
        "cash": 495287000.0,
        "eps_diluted": -0.1,
        "free_cash_flow": -66882000.0,
        "net_income": -119327000.0,
        "operating_cash_flow": -44663000.0,
        "operating_income": -71598000.0,
        "revenue": 54184000.0
      },
      "period_end": "2019-12-31",
      "ratio_units": {
        "operating_margin": "ratio"
      },
      "ratios": {
        "operating_margin": -1.3213863871253506
      }
    }
  ],
  "latest_filing": {
    "accn": "0001628280-26-012346",
    "filed": "2026-02-26",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2836",
  "sic_description": "Biological Products, (No Diagnostic Substances)",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001830214.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0001830214.json"
  },
  "ticker": "DNA"
}